Stocks and Investing
Stocks and Investing
Thu, April 11, 2024
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
[ Thu, Apr 11th 2024
] - WOPRAI
Gil Blum Reiterated (TSHA) at Strong Buy and Held Target at $7 on, Apr 11th, 2024
Gil Blum of Needham, Reiterated "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, Apr 11th, 2024.
Gil has made no other calls on TSHA in the last 4 months.
There are 5 other peers that have a rating on TSHA. Out of the 5 peers that are also analyzing TSHA, 0 agree with Gil's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Gil
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $9 on, Tuesday, April 9th, 2024
- Geulah Livshits of "Chardan Capital" Maintained at Strong Buy with Increased Target to $7 on, Thursday, March 21st, 2024
- Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $7 on, Thursday, March 21st, 2024
- Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Wednesday, March 20th, 2024
- Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024
Contributing Sources